Eagle Asset Management Inc Atara Biotherapeutics, Inc. Transaction History

Eagle Asset Management Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$7.53 - $14.93 $12.7 Million - $25.2 Million	-1,687,143 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$5.69 - $17.78 $374,276 - $1.17 Million	65,778 Added 4.06%	1,687,143 $14.4 Million
Q4 2019 Feb 07, 2020	SELL	$10.89 - $16.79 $150,009 - $231,282	-13,775 Reduced 0.84%	1,621,365 $26.7 Million
Q3 2019 Nov 04, 2019	BUY	$12.03 - $19.94 $369,176 - $611,918	30,688 Added 1.91%	1,635,140 $23.1 Million
Q2 2019 Aug 05, 2019	BUY	$19.05 - $41.04 $1.19 Million - $2.57 Million	62,690 Added 4.07%	1,604,452 $32.3 Million
Q1 2019 May 01, 2019	SELL	$28.4 - $41.74 $1.93 Million - $2.84 Million	-67,950 Reduced 4.22%	1,541,762 $61.3 Million
Q4 2018 Feb 11, 2019	SELL	$30.9 - $42.97 $471,101 - $655,120	-15,246 Reduced 0.94%	1,609,712 $55.9 Million
Q3 2018 Nov 08, 2018	BUY	$35.05 - $43.5 $5.76 Million - $7.14 Million	164,219 Added 11.24%	1,624,958 $67.2 Million
Q2 2018 Aug 07, 2018	SELL	$35.15 - $51.45 $907,854 - $1.33 Million	-25,828 Reduced 1.74%	1,460,739 $53.7 Million
Q1 2018 May 09, 2018	SELL	$18.0 - $48.35 $4,986 - $13,392	-277 Reduced 0.02%	1,486,567 $58 Million
Q4 2017 Feb 09, 2018	SELL	$13.2 - $18.1 $42,662 - $58,499	-3,232 Reduced 0.22%	1,486,844 $28.7 Million
Q3 2017 Nov 09, 2017	BUY	$13.25 - $17.05 $19.7 Million - $25.4 Million	1,490,076	1,490,076 $25.8 Million

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.25B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Eagle Asset Management Inc with notifications on news.